Increased Risk of Second Primary Malignancy and Mortality at ten Years After Stem Cell Transplant for Multiple Myeloma: An Analysis of 14,532 Patients-Reference-Cited by-同舟云学术

Increased Risk of Second Primary Malignancy and Mortality at ten Years After Stem Cell Transplant for Multiple Myeloma: An Analysis of 14,532 Patients

Published:2021-07-13 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Miles Brittany,Mackey James D

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference20 articles.

1. Second malignancies in patients with multiple myeloma;Law IP;Oncology,1977

2. Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS);Mailankody S;Blood,2011

3. Second malignancies after multiple myeloma: from 1960s to 2010s;Thomas A;Blood,2012

4. A review of second primary malignancy in patients with relapsed or refractory multiple myeloma treated with lenalidomide;Dimopoulos MA;Blood,2012

5. Connect MM® - the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide;Rifkin RM;Leuk Lymphoma,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: pomalidomide as maintenance after salvage autologous stem cell transplantation in a patient with relapsed multiple myeloma;Oncohematology;2023-12-07

2. Clinical Characteristics and Prognosis of Secondary Acute Lymphoblastic Leukemia in Patients with Multiple Myeloma during Long-Term Thalidomide Maintenance;Journal of Personalized Medicine;2023-02-25

3. Smoldering multiple myeloma: Reviewing the rationale for intervention;Leukemia & Lymphoma;2022-05-09

4. To transplant or not to transplant in multiple myeloma;Canadian Hematology Today;2022-03-01